ROSEMARY MILLER: Open Payments
NPI 1508847534 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 15 payments from 8 companies in 2025. Trend: 2023 $399 · 2024 $379 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 5 | $119 |
| Abbott Laboratories | 2 | $43 |
| Medtronic, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $30 |
| Tandem Diabetes Care, Inc. | 1 | $25 |
| Insulet Corporation | 1 | $21 |
| Sequel Med Tech, LLC | 1 | $21 |
| IBSA Pharma Inc. | 1 | $19 |
Products named: Dexcom G6 Transmitter, MINIMED 780G, MOUNJARO, FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, Omnipod, TWIIST, Tirosint.
Industry payments across PA — which companies pay providers there.
